Christopher Carroll
Director/M.D. | University of Florida
Gainesville, FL, UNITED STATES
Dr. Christopher Carroll is an expert in digital communication, an active researcher, and has written international guidelines for children.
Biography
Dr. Christopher Carroll’s research focuses mainly on the treatment of severe respiratory diseases (such as asthma and bronchiolitis) in children, the epidemiology of critical illness, and the use of digital communication. He is a recognized leader in digital communication and serves as deputy editor for web and multimedia for CHEST Journal, where he oversees the creation of post-publication multimedia content including podcasts, visual abstracts, and animations. Dr. Carroll also has been a long-standing proponent of the use of non-invasive therapies for children and led guideline development in this area.
Areas of Expertise (6)
Medical Education
Epidemiology of Critical Illness
Pediatric Critical Care
Pediatrics
Respiratory Illness in Children
Digital Communication
Media Appearances (2)
Doctors Might Have Been Focusing on the Wrong Asthma Triggers
The Atlantic online
2021-07-09
Nicole Lawson spent the beginning of the pandemic incredibly worried about her daughter, who has asthma. Five-year-old Scarlett’s asthma attacks were already landing her in the ER or urgent care every few months. Now a scary new virus was spreading. Respiratory viruses are known triggers of asthma attacks, and doctors also feared at the time that asthma itself could lead to more severe coronavirus infections. So Lawson’s family in Ohio hunkered down quickly and masked up often to keep Scarlett healthy.
Message from CHEST 2021 Co-Chair, Chris Carroll, MD, FCCP
CHEST Physician online
2021-05-13
A little over a year ago, none of us imagined we’d be where we are right now. The pandemic has deeply affected us all, and there have been so many losses, both professional and personal. I’m proud of how our CHEST community responded to the pandemic. The incredibly rapid pace of knowledge acquisition and the speed at which we disseminated that knowledge took a lot of combined effort, but that’s nothing new to our CHEST community.
Articles (3)
Noninvasive Respiratory Support for Pediatric Acute Respiratory Distress Syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference
Pediatric Critical Care Medicine JournalChristopher L. Carroll, et. al
2023-01-20
Objectives: To develop evidence-based recommendations for the Second Pediatric Acute Lung Injury Consensus Conference (PALICC) regarding the effectiveness of noninvasive respiratory support for pediatric acute respiratory distress syndrome (PARDS). These include consideration of the timing and duration of noninvasive ventilation (NIV) and high-flow nasal cannula (HFNC), whether effectiveness varies by disease severity or by characteristics of treatment delivery, and best practices for the use of NIV.
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
The New England Journal of MedicineMary Beth F. Son, et. al
2021-07-01
The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. We analyzed surveillance data on inpatients younger than 21 years of age who had MIS-C and were admitted to 1 of 58 U.S. hospitals between March 15 and October 31, 2020. The effectiveness of initial immunomodulatory therapy (day 0, indicating the first day any such therapy for MIS-C was given) with intravenous immune globulin (IVIG) plus glucocorticoids...
Changes in Pediatric ICU Utilization and Clinical Trends During the Coronavirus Pandemic
CHEST JournalJanine E. Zee-Cheng, et. al
2021-03-13
Background: Children have been less affected by the COVID-19 pandemic, but its repercussions on pediatric illnesses may have been significant. This study examines the indirect impact of the pandemic on a population of critically ill children in the United States. Research question: Were there significantly fewer critically ill children admitted to PICUs during the second quarter of 2020, and were there significant changes in the types of diseases admitted?
Social